|1.||Castoria, Gabriella: 3 articles (09/2009 - 11/2007)|
|2.||Auricchio, Ferdinando: 3 articles (09/2009 - 11/2007)|
|3.||Migliaccio, Antimo: 3 articles (09/2009 - 11/2007)|
|4.||Migliaccio, A: 2 articles (11/2012 - 10/2007)|
|5.||Lombardi, M: 2 articles (11/2012 - 10/2007)|
|6.||Auricchio, F: 2 articles (11/2012 - 10/2007)|
|7.||Barone, M V: 2 articles (11/2012 - 10/2007)|
|8.||Castoria, G: 2 articles (11/2012 - 10/2007)|
|9.||Yamaguchi, Hiroshi: 2 articles (07/2008 - 11/2007)|
|10.||Appella, Ettore: 2 articles (07/2008 - 11/2007)|
03/01/1981 - "The best treatment results in both groups were obtained in patients with estradiol receptor-positive tumors and less advanced disease. "
11/01/1990 - "In univariate analysis, UK-PA was a more powerful discriminator for disease-free interval than axillary node status, tumor size, or estradiol receptor. "
11/01/1990 - "In multivariate analysis, for both disease-free interval and survival, UK-PA was an independent risk factor, being independent of tumor size, axillary node status, and estradiol receptor. "
04/30/1979 - "To determine the correlation between the response to the estradiol receptor test and some fundamental properties of the tumor and the host, a study was conducted on 337 patients. "
01/01/1999 - "Moreover, the most important clinical prognosticators--tumor size and axillary lymph node involvement do not seem to be related to the estradiol receptor status. "
|2.||Breast Neoplasms (Breast Cancer)
09/01/1980 - "Measurement of estradiol receptor (105 patients including the previous 98 patients) was found to be less effective for guiding the prognosis of early breast cancer. "
01/01/1982 - "Disease-free interval and survival time of breast cancer patients were investigated in regard to the estradiol receptor (ER) status as measured in the corresponding primary tumours. "
01/01/1982 - "Estradiol receptor activity in human breast cancer, disease free interval and survival time."
01/01/2006 - "Different clinical impact of estradiol receptor determination according to the analytical method: A study on 1940 breast cancer patients over a period of 16 consecutive years."
11/01/1984 - "Studies on estradiol receptors in human mammary carcinomas."
|3.||Endometrial Neoplasms (Endometrial Cancer)
07/15/1984 - "With the use of an improved assay, all endometrial carcinomas were found to contain estradiol receptors; 81 of 92 (88%) contained measurable concentrations of progesterone receptors. "
11/01/1981 - "This study was designed to determine whether the presence of progesterone receptors (PR) and/or estradiol receptors (ER) could be used to predict progestin responsiveness of recurrent or advanced endometrial cancers. "
05/01/1995 - "In 156 patients with endometrial carcinoma, both estradiol receptor concentration and flow cytometrically estimated DNA content were measured on all patients and the patients were followed-up for over five years. "
09/01/1987 - "Estradiol receptors (ER) were measured in 71 and progesterone receptors (PR) in 62 primary endometrial carcinomas. "
01/01/1997 - "Studies suggest that detection of HSP27 in endometrial carcinoma, should not be considered as a method for identifying hormone-responsive tumors or indicator or presence of estradiol receptors. "
|4.||Neoplasm Metastasis (Metastasis)
01/01/1999 - "In our investigation, the length of disease free interval is similar in estradiol receptor positive and negative patients and in all sites of distant metastases, but it is significantly reduced if more than 4 axillary lymph nodes are involved. "
01/01/1999 - "Furthermore, the length of overall survival is independent on the type of distant metastases, with tendency to be longer in estradiol receptor positive than negative patients. "
01/01/1999 - "In addition, the overall survival is longer for estradiol receptor positive than negative patients and becomes reduced with more than 4 axillary lymph node metastases. "
01/01/1999 - "Its length is independent of the number of axillary lymph node metastases and the type of distant metastases, with a tendency to be longer in estradiol receptor positive than negative patients. "
01/01/1996 - "In contrast, there are numerous findings which confirm correlations between estradiol receptors and the localization, extent, and timing of distant metastasis. "
|5.||Brain Injuries (Brain Injury)
01/01/2000 - "The results demonstrate that estradiol exerts profound protective effects against ischemic brain injury induced by cerebral artery occlusion and that this protective action correlates with changes in the level of gene expression of estradiol receptors and members of the Bcl-2 family. "
|2.||Progesterone Receptors (Progesterone Receptor)
|5.||Tissue Plasminogen Activator (Alteplase)
|8.||Epidermal Growth Factor Receptor (EGF Receptor)
|2.||Transplantation (Transplant Recipients)